Markets:

Overview

News

Currencies

International

Treasuries

Atea Pharmaceuticals, Inc. - common stock (NQ:AVIR)

4.055 -0.185 (-4.36%)

Streaming Delayed Price Updated: 12:59 PM EST, Feb 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Atea Pharmaceuticals, Inc. - common stock

< Previous 1 2 3 4 5 6 7 8 Next >

Why Atea Pharmaceuticals Stock Is Sinking Today ↗

November 17, 2021

Roche calls it quits on the duo's attempt to develop an oral COVID-19 therapy.

Via The Motley Fool

Atea Shares Plunge As Roche Culls Partnership To Develop COVID-19 Pill ↗

November 17, 2021

Roche Holdings AG (OTC: RHHBY) has ended a partnership with Atea Pharmaceuticals Inc (NASDAQ: AVIR) to jointly develop a COVID-19 antiviral pill, a month...

Via Benzinga

The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment ↗

November 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Atea Announces Termination of Strategic Collaboration With Roche Atea...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 17, 2021

Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

Earnings Scheduled For November 11, 2021 ↗

November 11, 2021

Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million. • Reshape...

Via Benzinga

Expert Ratings For Atea Pharmaceuticals ↗

October 20, 2021

Over the past 3 months, 5 analysts have published their opinion on Atea Pharmaceuticals (NASDAQ:

Via Benzinga

25 Stocks Moving in Wednesday's Pre-Market Session ↗

November 17, 2021

Gainers 17 Education & Technology Group Inc. (NASDAQ: YQ) rose 283.5% to $3.16 in pre-market trading. 17 Education & Technology, earlier during the month, reported a $10...

Via Benzinga

Atea Pharma Stock Collapses As Roche Pulls The Plug On Pfizer-Rivaling Covid Pill ↗

November 16, 2021

Roche and Atea's partnership will end in February.

Via Investor's Business Daily

Atea Pharmaceuticals Inc (AVIR) Q3 2021 Earnings Call Transcript ↗

November 12, 2021

AVIR earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals? ↗

November 05, 2021

Photo by Danilo Alvesd on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

Is There Any Hope for Atea Pharmaceuticals Stock? ↗

November 04, 2021

If its coronavirus pill project can't be salvaged, it'll be trouble for investors.

Via The Motley Fool

3 Beaten-Down Biotech Stocks -- Can They Recover? ↗

October 31, 2021

Each for reasons of their own, Atea Pharmaceuticals, Omeros, and Novavax have had a very tough time this year.

Via The Motley Fool

How Atea's Clinical Flop Shakes Up the COVID-19 Pill Market ↗

October 29, 2021

Merck and Pfizer could benefit from Atea's setback.

Via The Motley Fool

Pfizer Conceding Race in Hospitalized Covid Because of Todos Medical's Triple MOA Antiviral ↗

October 28, 2021

Photo by Christina Victoria Craft on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a...

Via Benzinga

3 Top COVID Stocks -- Are They Tricks or Treats? ↗

October 26, 2021

Ghosts, goblins, ghouls? No, it's three vaccine stocks.

Via The Motley Fool

Was Atea Pharmaceutical's Flop Predictable? ↗

October 26, 2021

Were warning signs there for investors all along?

Via The Motley Fool

How The Future Looks For Last Week's Biggest Losers: Vinco Ventures, Atea Pharmaceuticals And More ↗

October 25, 2021

Last week, the five biggest stock market losers declined between about 75% and 37%. Below is a look at each stock and what they may have in the cards going forward. Galera...

Via Benzinga

Why Atea Pharmaceuticals Stock Got Crushed This Week ↗

October 22, 2021

A mid-stage trial miss caused investors to hit the exits this week.

Via The Motley Fool

10 Biggest Price Target Changes For Wednesday ↗

October 20, 2021

Mizuho cut QUALCOMM Incorporated (NASDAQ: QCOM) price target from $180 to $165. QUALCOMM shares fell 0.3% to $132.13 in pre-market trading. Deutsche Bank raised the price...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021 ↗

October 20, 2021

Upgrades For Iridium Communications Inc (NASDAQ:IRD...

Via Benzinga

Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher ↗

October 19, 2021

Toward the end of trading Tuesday, the Dow traded up 0.33% to 35,374.03 while the NASDAQ rose 0.54% to 15,103.67. The S&P also rose, gaining 0.55% to 4,511.35. The U.S. has...

Via Benzinga

Topics Stocks

52 Biggest Movers From Yesterday ↗

October 20, 2021

Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares climbed 42.6% to close at $9.51 on Tuesday. Xiaobai Maimai said Xiaobao An resigned as CEO. Kaival Brands Innovations Group...

Via Benzinga

Why Ulta and Atea Rained on the Nasdaq's Parade Tuesday ↗

October 19, 2021

Even with downward pressure from these two stocks, the Nasdaq Composite moved higher again.

Via The Motley Fool

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 19, 2021

Gainers Redhill Biopharma (NASDAQ:RDHL) stock increased by 18.27% to $5.76 during Tuesday's regular session. Redhill Biopharma's stock is trading at a volume of 2....

Via Benzinga

Mid-Day Market Update: Silver Surges 3%; Galera Therapeutics Shares Plunge ↗

October 19, 2021

Midway through trading Tuesday, the Dow traded up 0.47% to 35,423.05 while the NASDAQ rose 0.59% to 15,110.79. The S&P also rose, gaining 0.61% to 4,513.69. The U.S. has the...

Via Benzinga

Topics Stocks

Why Atea Pharmaceuticals Is Imploding Today ↗

October 19, 2021

The company's oral COVID-19 treatment looks like a dud in the mild-to-moderate COVID-19 setting.

Via The Motley Fool

AVIR Stock: The Oral Covid-19 Therapy News That Has Atea Pharmaceuticals Plunging Today ↗

October 19, 2021

Atea Pharmaceuticals (AVIR) stock is on the move Tuesday after providing an update from its Phase 2 Moonsong clinical trial update.

Via InvestorPlace

Atea Pharma Stock Crashes After Merck-Rivaling Covid Pill Lags In Midstage Test ↗

October 19, 2021

Atea Pharmaceuticals said its Covid pill didn't lower viral loads in all patients.

Via Investor's Business Daily

Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Boosts FY21 Guidance ↗

October 19, 2021

Following the market opening Tuesday, the Dow traded up 0.29% to 35,361.89 while the NASDAQ rose 0.31% to 15,068.75. The S&P also rose, gaining 0.39% to 4,503.81. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 19, 2021

Gainers Entasis Therapeutics Hldg (NASDAQ:ETTX) shares moved upwards by 16.72% to $3.63 during Tuesday's pre-market session. The company's market cap stands at $...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.